1. Emergent hid COVID-19 vaccine problems from FDA, report finds Full story

2. US may limit access to next-gen COVID-19 shots if funding falls short, official says Full story

3. Pfizer to buy Biohaven for $11.6B: 4 things to know Full story

4. ZYNRELEF (bupivacaine and meloxicam) extended-release solution becomes only product in its class separately reimbursed by CMS in the hospital outpatient department. Learn more and see full Prescribing Information, including Boxed Warning.

5. COVID-19 hospitalizations up in 37 states Full story

6. FDA extends shelf life for Eli Lilly's monoclonal antibody treatment Full story

7. Data is already spearheading cancer care breakthroughs. Here's how providers can keep the momentum going + take precision medicine to the next level.

8. 6 notes on rebound COVID-19 symptoms after Paxlovid Full story

9. Where are the 22 Leapfrog straight-'A' hospitals? Full story

10. Where are the 17 Leapfrog 'F' hospitals? Full story

11. Want to convert every missed call into a booked appointment? See how 1,000+ healthcare practices are automating front desk tasks to acquire and retain more patients here. 

12. Daily COVID-19 stats, state-by-state:

• Test positivity rates
• Percentage of population vaccinated
• Hospitalizations
• Death rates
• Booster rates

Becker's Learning Opportunities

1. Not all hospital-at-home programs are created equally. The best ones leverage AI to advance patient outcome improvements + lower costs. Here's how AI is driving program success.

2. MD Anderson, Cedars-Sinai and 3 other systems slashed length of stay for patients with bloodstream infections. See how the systems are optimizing antimicrobial utilization and improving outcomes here.

3. 85% of health insurance costs relate to chronic conditions. Here are 3 strategies to craft prevention programs that actually work.